The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions
Author:
Affiliation:
1. Institut für Studien zur Psychischen Gesundheit (ISPG) Mannheim Germany
2. Novartis Pharma GmbH Nuremberg Germany
Funder
Novartis Pharma GmbH
Publisher
Hindawi Limited
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.12374
Reference13 articles.
1. Drug delivery strategies for Alzheimer's disease treatment
2. Impact of Rivastigmine Patch and Capsules on Activities of Daily Living in Alzheimer’s Disease
3. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule
4. Randomized, Double-Blind, Parallel-Group, 48-Week Study for Efficacy and Safety of a Higher-Dose Rivastigmine Patch (15 vs. 10 cm2) in Alzheimers Disease
5. Rivastigmine Transdermal Patch
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phytochemical Compounds Loaded to Nanocarriers as Potential Therapeutic Substances for Alzheimer’s Disease-Could They be Effective?;Current Pharmaceutical Design;2022-08
2. Impact of interventions by a community pharmacist on care burden for people with dementia: development and randomized feasibility trial of an intervention protocol;Pilot and Feasibility Studies;2022-06-02
3. A Qualitative Study to Assess US Patient Preferences between new Transdermal System and Injectable Anabolic Therapies for Osteoporosis Treatment;Archives of Osteoporosis;2022-04-04
4. Memantine-Derived Schiff Bases as Transdermal Prodrug Candidates;ACS Omega;2022-03-28
5. Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population;British Journal of Clinical Pharmacology;2022-02-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3